Toponomics: studying protein-protein interactions and protein networks in intact tissue.
暂无分享,去创建一个
[1] Walter Schubert,et al. Fluorescence detection of protein clusters in individual cells and tissue sections by using toponome imaging system: sample preparation and measuring procedures , 2007, Nature Protocols.
[2] N. Goldstein,et al. Target validation and drug discovery using genomic and protein–protein interaction technologies , 2002, Expert opinion on therapeutic targets.
[3] A. Sorkin,et al. Endocytosis and intracellular trafficking of ErbBs. , 2009, Experimental cell research.
[4] W. Schubert,et al. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy , 2006, Nature Biotechnology.
[5] D. Hochstrasser,et al. From Proteins to Proteomes: Large Scale Protein Identification by Two-Dimensional Electrophoresis and Arnino Acid Analysis , 1996, Bio/Technology.
[6] R. Falk,et al. Approaches for systematic proteome exploration. , 2007, Biomolecular engineering.
[7] J. Keene,et al. The ribonome: a dominant force in co‐ordinating gene expression , 2009, Biology of the cell.
[8] F. Hofmann,et al. Cysteine-Rich Protein 2, a Novel Downstream Effector of cGMP/cGMP-Dependent Protein Kinase I-Mediated Persistent Inflammatory Pain , 2008, The Journal of Neuroscience.
[9] Henning Hofmeister,et al. In‐situ‐topoproteome analysis of cutaneous lymphomas: Perspectives of assistance for dermatohistologic diagnostics by Multi Epitope Ligand Cartography (MELC) , 2008 .
[10] R. W. Hansen,et al. The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.
[11] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[12] Qingming Luo,et al. Mass spectrometry in systems biology: an overview. , 2008, Mass spectrometry reviews.
[13] Henning Hofmeister,et al. Comparative in situ topoproteome analysis reveals differences in patch test‐induced eczema: cytotoxicity‐dominated nickel versus pleiotrope pollen reaction , 2009, Experimental dermatology.
[14] D. Figeys. Mapping the human protein interactome , 2008, Cell Research.
[15] L. Philipsen,et al. Systematic high-content proteomic analysis reveals substantial immunologic changes in colorectal cancer. , 2008, Cancer research.
[16] B. Bonnekoh,et al. Topo-Proteomic in situ Analysis of Psoriatic Plaque under Efalizumab Treatment , 2007, Skin Pharmacology and Physiology.
[17] G. Geisslinger,et al. The IKK‐NF‐κB pathway: a source for novel molecular drug targets in pain therapy? , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] Anirvan Ghosh,et al. Regulation of AMPA receptor recruitment at developing synapses , 2008, Trends in Neurosciences.
[19] Nikolai Kley,et al. Investigating the molecular basis of drug action and response: chemocentric genomics and proteomics. , 2006, Current drug targets.
[20] Christian Stephan,et al. Interlocking transcriptomics, proteomics and toponomics technologies for brain tissue analysis in murine hippocampus , 2008, Proteomics.
[21] Joanna Owens. 2006 drug approvals: finding the niche , 2007, Nature Reviews Drug Discovery.
[22] S. Grant,et al. Neuropathic Sensitization of Behavioral Reflexes and Spinal NMDA Receptor/CaM Kinase II Interactions Are Disrupted in PSD-95 Mutant Mice , 2003, Current Biology.
[23] B. Bonnekoh,et al. The CD11a Binding Site of Efalizumab in Psoriatic Skin Tissue as Analyzed by Multi-Epitope Ligand Cartography Robot Technology , 2006, Skin Pharmacology and Physiology.
[24] L. Philipsen,et al. Ulcerative Colitis Response Profiles in Crohn's Disease and Mucosa Reveals Distinctive Immune Proteomic Analysis of the Inflamed Intestinal , 2007 .
[25] Steven J Brown,et al. Sphingosine 1-phosphate receptor signaling. , 2009, Annual review of biochemistry.
[26] Gerd Geisslinger,et al. Toponomics analysis of drug-induced changes in arachidonic acid-dependent signaling pathways during spinal nociceptive processing. , 2009, Journal of proteome research.
[27] E. Golemis,et al. Resolving the network of cell signaling pathways using the evolving yeast two-hybrid system. , 2008, BioTechniques.
[28] Walter Schubert,et al. Topological proteomics, toponomics, MELK-technology. , 2003, Advances in biochemical engineering/biotechnology.
[29] Harald Gollnick,et al. Profiling lymphocyte subpopulations in peripheral blood under efalizumab treatment of psoriasis by multi epitope ligand cartography (MELC) robot microscopy. , 2006, European journal of dermatology : EJD.
[30] L. Langeberg,et al. The where's and when's of kinase anchoring. , 2006, Trends in biochemical sciences.
[31] Anne-Claude Gavin,et al. The social network of a cell: recent advances in interactome mapping. , 2008, Biotechnology annual review.
[32] C. Rongo,et al. The Ubiquitin Ligase RPM-1 and the p38 MAPK PMK-3 Regulate AMPA Receptor Trafficking , 2009, PloS one.
[33] Heribert Hirt,et al. Towards functional phosphoproteomics by mapping differential phosphorylation events in signaling networks , 2008, Proteomics.
[34] Kankan Wang,et al. Transcriptome and proteome analyses of drug interactions with natural products. , 2008, Current drug metabolism.
[35] Nicola Pimpinelli,et al. WHO-EORTC classification for cutaneous lymphomas. , 2005, Blood.
[36] BrainProfileDB – a platform for integration of functional genomics data , 2008, Proteomics.
[37] K. Scholich,et al. Toponomics Analysis of Functional Interactions of the Ubiquitin Ligase PAM (Protein Associated with Myc) during Spinal Nociceptive Processing*S , 2008, Molecular & Cellular Proteomics.
[38] Michael Meyer-Hermann,et al. Geometrically Repatterned Immunological Synapses Uncover Formation Mechanisms , 2006, PLoS Comput. Biol..